glp-1 news nov 2025 Novo Nordisk cuts forecast amid slower sales GLP-1 Trends

[Last accessed on 2022 Feb 27];Poster presented at:81st Scientific Sessions of the American Diabetes Association, June 25 -29, 2021 [Google Scholar] 28.Husain M, Birkenfeld AL, Donsmark M, Dungan K, Eliaschewitz FG, Franco DR, et al

Jin X, Qiu T, Li L, Yu R, Chen X, Li C, et al

Das Medikament Wegovy enthlt den gleichen Wirkstoff wie Ozempic, ist aber viel hher dosiert und ist von der Europischen Arzneimittelagentur EMA als Abnehmprparat zugelassen

The Weight Watchers difference: At 6 months, our Med+ members on the GLP-1 Success Program lost 27 lbs, on average.^ ^Based on a 6-month clinical trial (n=180) of individuals who were enrolled between FebruaryApril 2024, with overweight or obesity taking semaglutide or tirzepatide for weight loss and related outcomes through the WW Clinic Program and participating in the GLP-1 companion nutrition program